Table 6 Adjusted cost estimations of patients receiving RRT (DM and non-DM patients)
Author | Year | Stratification | Comparator | Estimation | Adjusted results ($,£,€ (95%CI) | p-value |
|---|---|---|---|---|---|---|
TX patients | ||||||
Li et al. [22] | 2016 | None | Increase in mean annual costs ($, GLM coefficient) for inpatient GLM | 1046 (734, 1359) | <0.05 | |
Increase in mean annual costs (GLM coefficient) for outpatient GLM | 593 (515, 671) | <0.05 | ||||
Dialysis patients (HD + PD) | ||||||
Li et al. [22] | 2016 | None | Increase in mean annual costs ($, GLM coefficient) for inpatient GLM | 1191 (929, 1453) | <0.05 | |
Increase in mean annual costs (GLM coefficient) for outpatient GLM | 248 (211, 284) | <0.05 | ||||
Grun et al. [23] | 2003 | Adjusted difference of means cost per day (₤, linear regression) linear | −0.8 (−11.8, 10.1) | 0.88 | ||
HD patients | ||||||
Hynes et al. [27] | 2012 | DM | Adjusted annual cost difference ($, GLM marginal effect) | −1623 (−14,973; 11,727) | 0.81 | |
Complicated DM | 8763 (−10,331; 27,857) | 0.37 | ||||
Icks et al. [31] | 2010 | None | Relative cost differences (euros, GLM) | 1.04 (0.98,1.10) | ||
Mau et al. [33] | 2010 | None | Case-mix-adjusted estimate | 0.0275 (0.0014) | ||
Relative cost | 1.03 | <0.001 | ||||
RRT patients | ||||||
Joyce et al. [32] | 2004 | None | Adjusted annual cost difference ($, GLM marginal effect ) | 42,361 | <0.001 | |